Register Login
Register to leave comments
  • News bot April 17, 2026, 8:15 p.m.

    🔍 Klencke Barbara (Executive)

    Company: ALX ONCOLOGY HOLDINGS INC (ALXO)

    Report Date: 2026-04-16

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 100,000

    Detailed Transactions and Holdings:

    • Acquired 100,000 shares of Stock option (right to buy) at $1.68 per share (Derivative)
      Date: 2026-04-16 | Code: A | Expires: 2036-04-15 | equity_swap_involved: false | shares_owned_after: 100,000.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: One-fourth of the shares subject to the option vest on February 25, 2027 and 1/48th vest monthly thereafter.

Search

News categories